For example, in patients with melanoma or NSCLC, ginseng polysaccharides (GPs) combined with anti-PD-1 therapy alters the gut microbiota and increases the abundance of SCAFs, especially valeric acid, but not acetic acid. The gene discussed is PDCD1; the disease is melanoma.